Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Biocryst Pharma Inc (BCRX)

Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Wed Dec 4, 3:15PM CST

BCRX : 7.57 (+2.44%)
BioCryst Pharmaceuticals' ORLADEYO® Recommended for Routine Prevention of Hereditary Angioedema Attacks in Ireland Quiver Quantitative, Inc. - Mon Nov 18, 11:12AM CST

BioCryst Pharmaceuticals announces HSE recommendation for ORLADEYO® to prevent hereditary angioedema attacks in eligible patients aged 12 and older.Quiver AI SummaryBioCryst Pharmaceuticals announced...

BCRX : 7.57 (+2.44%)
BioCryst Launches ORLADEYO® (berotralstat) in Ireland GlobeNewswire - Mon Nov 18, 1:00AM CST

BCRX : 7.57 (+2.44%)
BioCryst to Present at Upcoming Investor Conferences GlobeNewswire - Wed Nov 6, 6:00AM CST

BCRX : 7.57 (+2.44%)
BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire - Tue Nov 5, 6:00AM CST

BCRX : 7.57 (+2.44%)
BioCryst Pharmaceuticals (BCRX) Q3 2024 Earnings Call Transcript Motley Fool - Mon Nov 4, 1:30PM CST

BCRX earnings call for the period ending September 30, 2024.

BCRX : 7.57 (+2.44%)
BioCryst: Q3 Earnings Snapshot AP - Mon Nov 4, 6:06AM CST

BioCryst: Q3 Earnings Snapshot

BCRX : 7.57 (+2.44%)
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Mon Nov 4, 6:00AM CST

BCRX : 7.57 (+2.44%)
BioCryst Presents New Real-World Evidence Showing High Adherence and Persistence Rates with ORLADEYO® (berotralstat) GlobeNewswire - Thu Oct 24, 7:00AM CDT

BCRX : 7.57 (+2.44%)
BioCryst to Report Third Quarter 2024 Financial Results on November 4 GlobeNewswire - Mon Oct 21, 6:00AM CDT

BCRX : 7.57 (+2.44%)

Barchart Exclusives

Oracle Stock Is Off Its Highs and Could Be Cheap Here Barchart - Sun Dec 22, 9:30AM CST
Oracle Corp. produced higher revenue in Q2 but lower free cash flow and FCF margins. However, ORCL stock is now off its highs and could be undervalued here. Shorting out-of-the-money puts is one way to play it. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot